Dr. Yinghong Wang
Claim this profileM D Anderson Cancer Center
Studies Cancer
Studies Inflammatory Bowel Disease
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Yinghong Wang is currently running
Fecal Microbiota Transplantation
for Skin Cancer
This trial studies the role of the gut microbiome and effectiveness of a fecal transplant on medication-induced gastrointestinal (GI) complications in patients with melanoma or genitourinary cancer. The gut microbiome (the bacteria and microorganisms that live in the digestive system) may affect whether or not someone develops colitis (inflammation of the intestines) during cancer treatment with immune-checkpoint inhibitor drugs. Studying samples of stool, blood, and tissue from patients with melanoma or genitourinary cancer may help doctors learn more about the effects of treatment on cells, and help doctors understand how well patients respond to treatment. Treatment with fecal transplantation may help to improve diarrhea and colitis symptoms.
Recruiting1 award Phase 1 & 212 criteria
Infliximab vs Vedolizumab
for Colitis from Immunotherapy in Cancer Patients
This phase I/II trial studies the side effects of infliximab and vedolizumab and to see how well they work in treating inflammation of the colon (colitis) caused by immune checkpoint inhibitor therapy in patients with cancer of the genital and urinary organs (genitourinary) or melanoma. Monoclonal antibodies, such as infliximab or vedolizumab, may help to treat immunotherapy induced colitis/diarrhea. This study may help to identify the optimal treatment strategy for immune checkpoint inhibitor-related colitis in patients with genitourinary cancer or melanoma.
Recruiting1 award Phase 1 & 26 criteria
More about Yinghong Wang
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Yinghong Wang has experience with
- Fecal Microbiota Transplantation
- Infliximab
- Vedolizumab
- Prednisone
Breakdown of trials Yinghong Wang has run
Cancer
Inflammatory Bowel Disease
Colitis
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yinghong Wang specialize in?
Yinghong Wang focuses on Cancer and Inflammatory Bowel Disease. In particular, much of their work with Cancer has involved treating patients, or patients who are undergoing treatment.
Is Yinghong Wang currently recruiting for clinical trials?
Yes, Yinghong Wang is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Yinghong Wang has studied deeply?
Yes, Yinghong Wang has studied treatments such as Fecal Microbiota Transplantation, Infliximab, Vedolizumab.
What is the best way to schedule an appointment with Yinghong Wang?
Apply for one of the trials that Yinghong Wang is conducting.
What is the office address of Yinghong Wang?
The office of Yinghong Wang is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.